English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/137497
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Efficient stereoselective synthesis of 2-acetamido-1,2- dideoxyallonojirimycin (DAJNAc) and sp2-iminosugar conjugates: Novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme

AutorFuente, Alex de la; Rísquez-Cuadro, Rocio; Verdaguer, Xavier; García-Fernández, José Manuel; Nanba, Eji; Higaki, Katsumi; Ortiz-Mellet, Carmen; Riera, Antoni
Palabras claveHexosaminidase inhibitors
Stereoselective synthesis
Pharmacological chaperones
Tay-Sachs disease
sp2-iminosugars
Fecha de publicación2016
EditorElsevier
CitaciónEuropean Journal of Medicinal Chemistry, 121: 926-938 (2016)
ResumenDue to their capacity to inhibit hexosaminidases, 2-acetamido-1,2-dideoxy-iminosugars have been widely studied as potential therapeutic agents for various diseases. An efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc), the most potent inhibitor of human placenta b-Nacetylglucosaminidase (b-hexosaminidase) among the epimeric series, is here described. This novel procedure can be easily scaled up, providing enough material for structural modifications and further biological tests. Thus, two series of sp2-iminosugar conjugates derived from DAJNAc have been prepared, namely monocyclic DAJNAc-thioureas and bicyclic 2-iminothiazolidines, and their glycosidase inhibitory activity evaluated. The data evidence the utmost importance of developing diversity-oriented synthetic strategies allowing optimization of electrostatic and hydrophobic interactions to achieve high inhibitory potencies and selectivities among isoenzymes. Notably, strong differences in the inhibition potency of the compounds towards b-hexosaminidase from human placenta (mature) or cultured fibroblasts (precursor form) were encountered. The ensemble of data suggests that the ratio between them, and not the inhibition potency towards the placenta enzyme, is a good indication of the chaperoning potential of TaySachs disease-associated mutant hexosaminidase
Versión del editorhttp://dx.doi.org/10.1016/j.ejmech.2015.10.038
URIhttp://hdl.handle.net/10261/137497
DOI10.1016/j.ejmech.2015.10.038
Aparece en las colecciones: (IIQ) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
García et al..pdf1,22 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.